Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer
Novartis Pharmaceuticals
Seock-Ah Im; Yen-Shen Lu; Aditya Bardia; Nadia Harbeck; Marco Colleoni; Fabio Franke; Louis Chow; Joohyuk Sohn; Keun-Seok Lee; Saul Campos-Gomez; Rafael Villanueva-Vazquez; Kyung-Hae Jung; Arunava Chakravartty; Gareth Hughes; Ioannis Gounaris; Karen Rodriguez-Lorenc; Tetiana Taran; Sara Hurvitz; Debu Tripathy